𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients

✍ Scribed by K. Ming Chan; Fay J. Strohschein; David Rydz; Amyn Allidina; Ashfaq Shuaib; Chris F. Westbury

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
86 KB
Volume
33
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The purpose of this study was to test whether modafinil is effective in alleviating the symptoms of fatigue in postpolio patients, because it has been helpful for such symptoms in other neurologic disorders. Using a double‐blind, randomized, placebo‐controlled cross‐over design, 14 postpolio patients with moderate to severe fatigue were assigned to receive modafinil or placebo first. Piper Fatigue Scale, Epworth Sleepiness Scale, digit span, and reaction time tests were done at baseline and then at weekly intervals. The Piper Fatigue Scale scores improved by 27 ± 40% (mean ± SD) following modafinil and by 43 ± 36% following placebo. Scores for most of the other tests did not change during the study. Therefore, we conclude that modafinil was not effective in alleviating the symptoms of fatigue in postpolio patients. Muscle Nerve, 2005

📜 SIMILAR VOLUMES

Randomized trial of modafinil for treati
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease
✍ Charles H. Adler; John N. Caviness; Joseph G. Hentz; Marlene Lind; Judy Tiede 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract We assessed the safety and efficacy of modafinil for the treatment of excessive daytime sleepiness in patients with Parkinson's disease (PD). This was a single‐site, randomized, double‐blind, placebo‐controlled crossover study of 21 PD patients having an Epworth Sleepiness Scale (ESS) s

A randomized, controlled crossover trial
A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue
✍ Jeremy J. Theal; Mohssen N. Toosi; Larisa Girlan; Ronald J. Heslegrave; Pierre-M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Fatigue is common in primary biliary cirrhosis (PBC). Altered central serotonergic neurotransmission may be involved in its pathogenesis. This multicenter, randomized, double-blind, placebo-controlled, crossover trial evaluated the efficacy of ondansetron, a selective 5-HT3 receptor subtype antagoni

Randomized controlled trial of interfero
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
✍ Josep M. Llovet; Margarita Sala; Lluís Castells; Yanette Suarez; Ramon Vilana; L 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

The aim of this randomized controlled trial was to assess the efficacy of interferon alfa-2b (IFN) for the treatment of advanced hepatocellular carcinoma (HCC). Fifty-eight patients with HCC who were not suitable for resection, transplantation, ethanol injection, or arterial embolization were strati

A randomized controlled trial of rituxim
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
✍ S. De Vita; L. Quartuccio; M. Isola; C. Mazzaro; P. Scaini; M. Lenzi; M. Campani 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

## Abstract ## Objective To conduct a long‐term, prospective, randomized controlled trial evaluating rituximab (RTX) therapy for severe mixed cryoglobulinemia or cryoglobulinemic vasculitis (CV). ## Methods Fifty‐nine patients with CV and related skin ulcers, active glomerulonephritis, or refrac

Randomized Controlled Trial of Quinacrin
Randomized Controlled Trial of Quinacrine for the Treatment of HBsAg-Positive Chronic Hepatitis
✍ Henry C. Bodenheimer Jr.; Fenton Schaffner; Salvatore Vernace; Shalom Z. Hirschm 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 1 views

Several drugs which react with DNA decrease hepatitis B viral (HBV) DNA polymerase activity in vitro. Because such an alteration of viral replication, if produced in patients with hepatitis B surface antigen (HBsAg)-positive chronic hepatitis, may lead to elimination of viral infection, we conducted